Compare Nuwellis Inc (NUWE) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Sana Biotechnology Inc — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Sana Biotechnology Inc is far larger — about 801.7× Nuwellis Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SANA | |
|---|---|---|
Market Cap | $1.09M | $873.84M |
Sector | Technology | Health |
52-Week High | $527.46 | $5.92 |
52-Week Low | $2.80 | $2.68 |
Enterprise Value | -$722.58K | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
